Biotech firm NewLimit, co-founded by Coinbase CEO Brian Armstrong, has secured a significant $130 million in funding through a Series B round. This investment from Kleiner Perkins will […]
Brian Armstrong’s Venture Invests in Age Reversal Biotech with $130 Million Funding Round
Coinbase CEO Brian Armstrong has ventured into the world of biotech, supporting a company aiming to reverse the effects of aging. Through his startup, NewLimit, they’re developing treatments […]
NewLimit Secures $130 Million Series B Funding to Advance Anti-Aging Research
Biotechnology firm NewLimit has received a significant $130 million Series B funding round, led by the renowned venture capital firm Kleiner Perkins. This investment underscores the potential of […]